Eular recommendations for vasculitis

Eular recommendations for vasculitis

Opis bibliograficzny
Główni autorzy:	Luqmani, R, Mukhtyar, C, Guillevin, L
Format:	Conference item
Wydane:	2007

Podobne zapisy

EULAR recommendations for the management of large vessel vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2009)

EULAR recommendations for the management of primary small and medium vessel vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2009)

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS
od: Yates, M, i wsp.
Wydane: (2016)

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
od: Yates, M, i wsp.
Wydane: (2016)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
od: Hellmich, B, i wsp.
Wydane: (2006)

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis
od: Yates, M, i wsp.
Wydane: (2016)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
od: Mukhtyar, C, i wsp.
Wydane: (2007)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
od: Hellmich, B, i wsp.
Wydane: (2007)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
od: Luqmani, R, i wsp.
Wydane: (2007)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
od: Yates, M, i wsp.
Wydane: (2017)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
od: Luqmani, R, i wsp.
Wydane: (2011)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
od: Mukhtyar, C, i wsp.
Wydane: (2008)

Outcome in systemic vasculitis.
od: Luqmani, R, i wsp.
Wydane: (1998)

New imaging strategy for large vessel vasculitis (based on the EULAR-2023 recommendations)
od: O. N. Egorova, i wsp.
Wydane: (2023-12-01)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
od: Craven, A, i wsp.
Wydane: (2013)

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.
od: Basu, N, i wsp.
Wydane: (2010)

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2007)

Cardiovascular involvement in primary systemic vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2009)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
od: Luqmani, R, i wsp.
Wydane: (2009)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
od: T. V. Beketova
Wydane: (2017-03-01)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
od: Mukhtyar, C, i wsp.
Wydane: (2009)

Outpatient assessment of systemic vasculitis.
od: Nataraja, A, i wsp.
Wydane: (2007)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
od: Sara Monti, i wsp.
Wydane: (2023-07-01)

The role of biologic therapies in the management of systemic vasculitis.
od: Chan, A, i wsp.
Wydane: (2006)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2006)

Cardiovascular outcomes in ANCA associated vasculitis
od: Mukhtyar, C, i wsp.
Wydane: (2008)

Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
od: Ricardo Blanco, i wsp.
Wydane: (2022-11-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
od: T. V. Beketova
Wydane: (2023-10-01)

Assessing ACR/EULAR provisional 2017 classification criteria for granulomatosis with polyangiitis (GPA) in a cohort of 376 children with small to medium vessel chronic vasculitis - a pediatric vasculitis initiative (PedVas) study
od: Rivera, A, i wsp.
Wydane: (2017)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV
od: Sara Monti, i wsp.
Wydane: (2023-06-01)

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis
od: Coates, L, i wsp.
Wydane: (2017)

Correction: Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
Wydane: (2023-06-01)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
od: Suppiah, R, i wsp.
Wydane: (2011)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
od: Suppiah, R, i wsp.
Wydane: (2011)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
od: Luqmani, R, i wsp.
Wydane: (2007)

Vaccination in rheumatology (the 2019 update of EULAR recommendations)
od: B. S. Belov, i wsp.
Wydane: (2019-12-01)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
od: Mukhtyar, C, i wsp.
Wydane: (2009)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
od: Mukhtyar, C, i wsp.
Wydane: (2008)

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.
od: Zhang, W, i wsp.
Wydane: (2010)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
od: Suppiah, R, i wsp.
Wydane: (2011)